The independent source for health policy research, polling, and news.
With federal investigators bearing down on his committee, Rep. Tom Price, R-Ga., who is line to be secretary of the Department of Health and Human Services, showed little restraint in investing in health companies.
Kaiser Health News reporter Shefali Luthra discusses the controversy surrounding Kaleo, a company that makes a life-saving auto-injector for opioid drug overdoses on Weekend Edition.
The state passed a bailout to make ACA plans more affordable, defeated a plan to offer bare bones insurance and is floating a state-sponsored public option.
People who think the change in administrations may save them from having to pay a fine for not having insurance in 2016 could be in for a rude surprise.
Luke Whitbeck’s life was saved by a rare disease drug, but it costs $300,000 a year.
Humor may be an antidote for the pain of death for both patients and survivors.
Republicans, who don’t have the votes to repeal the ACA directly, are hoping to use this strict budget strategy that requires only a majority vote to strip the health law of provisions they oppose.
California state Sen. Ricardo Lara talks about progress and setbacks in the Trump era.
Many seniors are denied coverage because therapists mistakenly believe that they must be making improvements to qualify for coverage.
Employer medical insurance still covers more people than any other kind. A Republican replacement for Obamacare could spread instability beyond the health law’s shaky marketplace plans.
A bill recently introduced in the California legislature would require insurance companies to cover fertility-preserving services for patients at risk of infertility because of necessary medical treatments.
Republicans hope to expand the use of health savings accounts to encourage consumers to be more judicious in using their coverage. Here’s an explainer of how they work.
With announcements of placements in residencies expected in March, medical education groups and hospitals say they’re unsure how to proceed.
Despite questions about Lupron’s lasting side effects and minimal study into its safety, the FDA sped approval of the drug to market. Years later, some young women are still living with the consequences.
Indiana asked the Trump administration Tuesday to renew funding for its Medicaid expansion under the health law, which is due to expire in January 2018.
Concerns over U.S. Rep. Tom Price’s answers about stock trades led Senate Democrats to boycott a committee vote that would have moved his nomination to the Senate floor.
One part of the federal health law gave hospitals financial incentives to improve patient care. Some invested big to make those changes and are worried about what losing that support would mean.
A new study, though small, finds extensive damage to commonly used medical scopes that could trap dangerous bacteria. That raises concerns about the potential for more outbreaks.
An expert geriatrician says the benefits for the patient, such as alleviating pain and maintaining independence, must be weighed against the possible risks. Her motto: ‘start low and go slow.’
Consumer advocates warn that these policies don’t have important safeguards that customers need.
